Decreased EPC mobilization and differentiation have also been observed in chronic inflammatory diseases, including preeclampsia and rheumatoid arthritis5,11, and these effects can be rescued by treatment with the anti-inflammatory drug dexamethasone and the anti-TNF-α antibody infliximab11. This evidence concerns the gene TNF and preeclampsia.